Tradestie Institutional Equity Comparison Engine
OKYO vs MAIA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
MAIA Overall Edge
MAIA Captures Institutional Edge (2โ1 Pillars ยท 3โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to MAIA Biotechnology, Inc. (MAIA) driven by superior Valuation, Momentum & Technical while OKYO counters with relative strength in Growth & Margin. Fundamentally, OKYO trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus MAIA at 1.2x Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, OKYO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against MAIA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
MAIA
OKYO N/M vs MAIA 1.2x Fwd P/E
Growth & Margin Winner
OKYO
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner
MAIA
1Y -47.0% vs +20.6% ยท 52W Pos 3% vs 10%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
OKYO
NASDAQ
OKYO Pharma Limited Ordinary Shares
Biological Products, (No Diagnostic Substances)
$1.07
-7.76% 1D
Market Cap
$62.7M
1M Return
-27.21%
1Y Return
-47.03%
Forward P/E
N/M
Unified AI Score
42.8 / 100
HOLD
Tech 38.0
Fund 54.0
Flow 50.0
Mom 45.0
MAIA
NYSE American
MAIA Biotechnology, Inc.
Pharmaceutical Preparations
$1.11
-2.63% 1D
Market Cap
$68.5M
1M Return
-1.77%
1Y Return
+20.65%
Forward P/E
1.2x
Unified AI Score
37.6 / 100
SELL
Tech 40.0
Fund 38.0
Flow 50.0
Mom 44.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
OKYO -47.03%
MAIA +20.65%
Spread: +67.68 pp (MAIA Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
OKYO TTM Op. Margin: 0.0%
MAIA TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on OKYO vs MAIA. Trailing 12-month operating profitability (OKYO 0.0% vs MAIA 0.0%) and valuation multiples (OKYO N/M vs MAIA 1.2x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | OKYO | MAIA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $62.7M | $68.5M | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | 1.2x | Lower Multiple | MAIA |
| Forward P/E Ratio Valuation | N/M | 1.2x | Lower Multiple | MAIA |
| Revenue Growth (YoY) Growth | +0.0% | +0.0% | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -263.8% | -341.5% | Higher ROE | OKYO |
| 52-Week Range Position Momentum | 3% ($1โ$3) | 10% ($1โ$3) | Stronger Trend | MAIA |
| Beta / 30D Volatility Risk Regime | 1.00ฮฒ ยท 76% Vol | 1.65ฮฒ ยท 108% Vol | Lower Realized Risk | OKYO |
| Unified Institutional Score Composite Signal | 42.8 / 100 (HOLD) | 37.6 / 100 (SELL) | Higher Composite | OKYO |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full OKYO vs MAIA Buy Guide
OKYO
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
MAIA
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither OKYO nor MAIA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.